Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E2XP
|
||||
Former ID |
DNC007894
|
||||
Drug Name |
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]linoleamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529162] | ||
Structure |
Download2D MOL |
||||
Formula |
C28H42N2O2
|
||||
Canonical SMILES |
CCCCCC=CCC=CCCCCCCCC(=O)NCCC1=CNC2=C1C=C(C=C2)O
|
||||
InChI |
1S/C28H42N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-28(32)29-21-20-24-23-30-27-19-18-25(31)22-26(24)27/h6-7,9-10,18-19,22-23,30-31H,2-5,8,11-17,20-21H2,1H3,(H,29,32)/b7-6-,10-9-
|
||||
InChIKey |
YJVMJUDLMFBYFZ-HZJYTTRNSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Vanilloid receptor 1 | Target Info | Inhibitor | [529162] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | ||||
Trk receptor signaling mediated by PI3K and PLC-gamma | |||||
Reactome | TRP channels | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.